Identifiability of enzyme kinetic parameters in substrate competition: a case study of CD39/NTPDase1

被引:0
|
作者
McGuinness, Anna N. [1 ]
Tahir, Aman [1 ]
Sutton, Nadia R. [1 ,2 ,3 ]
Marquis, Andrew D. [4 ,5 ]
机构
[1] Michigan Med, Dept Med, Div Cardiovasc Med, Ann Arbor, MI USA
[2] Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Nashville, TN USA
[3] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN USA
[4] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA
[5] Appl BioMath, Concord, MA 01742 USA
关键词
Enzyme kinetics; Substrate competition; Parameter estimation; Identifiability; CD39; NTPDase1; Ectonucleotidase; ATP-DIPHOSPHOHYDROLASE; PURIFICATION; HYDROLYSIS;
D O I
10.1007/s11302-023-09942-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD39 (NTPDase1-nucleoside triphosphate diphosphohydrolase 1) is a membrane-tethered ectonucleotidase that hydrolyzes extracellular ATP to ADP and ADP to AMP. This enzyme is expressed in a variety of cell types and tissues and has broadly been recognized within vascular tissue to have a protective role in converting "danger" ligands (ATP) into neutral ligands (AMP). In this study, we investigate the enzyme kinetics of CD39 using a Michaelis-Menten modeling framework. We show how the unique situation of having a reaction product also serving as a substrate (ADP) complicates the determination of the governing kinetic parameters. Model simulations using values for the kinetic parameters reported in the literature do not align with corresponding time-series data. This dissonance is explained by CD39 kinetic parameters previously being determined by graphical/linearization methods, which have been shown to distort the underlying error structure and lead to inaccurate parameter estimates. Modern methods of estimating these kinetic parameters using nonlinear least squares are still challenging due to unidentifiable parameter interactions. We propose a workflow to accurately determine these parameters by isolating the ADPase and ATPase reactions and estimating the respective ADPase parameters and ATPase parameters with independent data sets. Theoretically, this ensures all kinetic parameters are identifiable and reliable for future prospective model simulations involving CD39. These kinds of mathematical models can be used to understand how circulating purinergic nucleotides affect disease etiology and potentially inform the development of corresponding therapies.
引用
收藏
页码:257 / 271
页数:15
相关论文
共 50 条
  • [41] Heterologous cell-cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1)
    Marcus, AJ
    Broekman, MJ
    Drosopoulos, JHF
    Islam, N
    Pinsky, DJ
    Sesti, C
    Levi, R
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (12) : 2497 - 2509
  • [42] Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury
    Grenz, Almut
    Zhang, Hua
    Hermes, Marina
    Eckle, Tobias
    Klingel, Karin
    Huang, Dan Yang
    Mueller, Christa E.
    Robson, Simon C.
    Osswald, Hartmut
    Eltzschig, Holger K.
    FASEB JOURNAL, 2007, 21 (11): : 2863 - 2873
  • [43] Role of E-NTPDase1/CD39 in ATP-induced modulation of norepinephrine exocytosis in heart
    Machida, T
    Heerdt, PM
    Reid, AC
    Schafer, U
    Silver, RB
    Hirafuji, M
    Broekman, MJ
    Marcus, AJ
    Levi, R
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 229P - 229P
  • [44] Expression, purification and crystallization of the ecto-enzymatic domain of rat E-NTPDase1 CD39
    Zhong, Xiaotian
    Buddha, Madhavan
    Guidotti, Guido
    Kriz, Ron
    Somers, Will
    Mosyak, Lidia
    ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2008, 64 : 1063 - 1065
  • [45] Antenatal Dexamethasone Treatment Induces Sex-dependent Upregulation of NTPDase1/CD39 and Ecto-5MODIFIER LETTER PRIME-nucleotidase/CD73 in the Rat Fetal Brain
    Manojlovic-Stojanoski, Milica
    Lavrnja, Irena
    Stevanovic, Ivana
    Trifunovic, Svetlana
    Ristic, Natasa
    Nestorovic, Natasa
    Sevigny, Jean
    Nedeljkovic, Nadezda
    Laketa, Danijela
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2022, 42 (06) : 1965 - 1981
  • [46] Evaluation of the genes encoding CD39/NTPDase-1 and CD39L1/NTPDase-2 in horses with and without abnormal hemorrhage and in horses with pathologic evidence of exercise-induced pulmonary hemorrhage
    Boudreaux, Mary K.
    Koehler, Jennifer
    Habecker, Perry L.
    Del Piero, Fabio
    VETERINARY CLINICAL PATHOLOGY, 2015, 44 (04) : 617 - 625
  • [47] Neovascularization in radiation-induced proctitis is associated with increased endothelial cell expression of NTPDase-1/CD39
    Sheth, SG
    Greenberg, HL
    Pleskow, DK
    Anastopoulos, H
    Farrell, RJ
    Qawi, I
    Csizmadias, E
    Lamont, JT
    Robson, SC
    GASTROENTEROLOGY, 2001, 120 (05) : A40 - A41
  • [48] The ENTPD1 promoter polymorphism-860 A > G (rs3814159) is associated with increased gene transcription, protein expression, CD39/NTPDase1 enzymatic activity, and thromboembolism risk
    Maloney, James P.
    Branchford, Brian R.
    Brodsky, Gary L.
    Cosmic, Maxwell S.
    Calabrese, David W.
    Aquilante, Christina L.
    Maloney, Kelly W.
    Gonzalez, Joseph R.
    Zhang, Weiming
    Moreau, Kerrie L.
    Wiggins, Kerri L.
    Smith, Nicholas L.
    Broeckel, Ulrich
    Di Paola, Jorge
    FASEB JOURNAL, 2017, 31 (07): : 2771 - 2784
  • [49] Ectonucleoside triphosphate diphosphohydrolase-1 (E-NTPDase1/CD39) as a new prognostic marker in chronic lymphocytic leukemia
    Abousamra, Nashwa Khairat
    El-Din, Manal Salah
    Elzahaf, Eman Hamza
    Esmael, Mohammed Ebrahim
    LEUKEMIA & LYMPHOMA, 2015, 56 (01) : 113 - 119
  • [50] Heterologous cell-cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1) (vol 1, pg 2497, 2003)
    Marcus, AJ
    Broekman, MJ
    Drosopoulos, JHF
    Islam, N
    Pinsky, DJ
    Sesti, C
    Levi, R
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (04) : 682 - 682